ICON plc
A Research Scientist at ICON in Lenexa, Kansas leads global client programs focused on developing assay strategies and advancing clinical therapies. The role involves independently directing the method development and validation of LC/MS/MS assays for preclinical and clinical specimens, including small molecules, radiolabeled compounds, and biologics. Candidates will collaborate cross-functionally to transfer robust analytical methods and support new business opportunities through technical consulting.
ICON plc is a global clinical research organisation (CRO) that provides outsourced clinical development and commercialisation services to pharmaceutical, biotechnology and medical device companies. It offers end-to-end drug and device development support — including clinical trial management across phases, data management and biostatistics, regulatory and safety/pharmacovigilance, and commercialisation and market-access services. ICON combines scientific and therapeutic expertise with technology and a scalable global operations network to accelerate development and bring therapies to patients. Clients engage ICON for integrated, experienced CRO support across the full product lifecycle.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON plc.
Right around the average for this role
Analyst II – Bioanalytical Method Development LC-MS/MS
KCAS Bio
Senior Scientist, II Biologics & Genetic Medicine - LCMS Characterization & Bioanalysis
AbbVie
Bioanalytical Laboratory Technician
Celerion
Associate Director, Bioanalysis LCMS
State of Louisiana
Senior Principal Scientist
Novo Nordisk A/S
PK Bioanalysis Director
Exelixis